Probi and Ipsen sign distribution agreement for probiotic LP299V
Ipsen and Probi joint press release
Ipsen and Probi have reached an agreement covering 18 countries — primarily within the European Union and emerging markets — for the commercialization of Probi’s probiotic strain Lactobacillus plantarum 299v.
No comments:
Post a Comment